Stockreport

Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF The company reported earnings of 21 cents per ADS in the year-ago quarter. The bottom line was hit by a one-time acquisition cost and impairment charge on non-current [Read more]